Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis

European Journal of Pharmacology
Bartlomiej KalaskaWlodzimierz Buczko

Abstract

Heparin is a natural polymer widely used in medicine especially during the treatment of cardiovascular diseases since it is a potent blood anticoagulant. In case of emergency, e.g., massive hemorrhage, the anticoagulant activity of heparin has to be quickly stopped by the administration of a heparin reversing agent. Currently protamine sulfate, an allergenic protein, is used for this purpose. We are reporting the studies on a new polymeric substance, a cationic dextran derivative, which is able to form complexes with heparin. Dextran is a blood compatible polymer which is also frequently applied in medicine. By substituting dextran with glycidyltrimethylammonium chloride a cationic polymer was obtained that in vitro binds to heparin with an efficiency similar to that of protamine. To investigate the influence of modified dextran on the reversal of conventional heparin we used the models of experimental arterial thrombosis induced by electrical stimulation and chemically induced venous thrombosis. A decrease in bleeding time and activated partial thromboplastin time after administration of the cationic dextran to heparinized rats was found. Moreover, other routinely measured blood parameters are significantly affected. Modified ...Continue Reading

References

Jun 1, 1989·European Journal of Vascular Surgery·B Lindblad
Sep 25, 1971·Lancet·V V KakkarP T Flute
Mar 1, 1984·Clinical Cardiology·C L HollandW Fang
Feb 1, 1980·Journal of Pharmacological Methods·D C Cardinal, R J Flower
Jan 1, 1980·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·W CullmannP Jürgens
Jul 1, 1995·Anesthesia and Analgesia·J H LevyA Morales
Apr 1, 1996·Journal of Pharmacological and Toxicological Methods·S Guarini
Nov 13, 2001·British Journal of Haematology·A J ChuN Ramos
May 14, 2003·Chromosoma·John D LewisJuan Ausió
Jul 30, 2004·Seminars in Thrombosis and Hemostasis·Timothy A Mixon, Gregory J Dehmer
Jul 30, 2005·Anesthesiology·Mark Stafford-SmithUNKNOWN Members of the Global Perioperative Research Organization
Sep 1, 2005·Anesthesiology·Ian J Welsby, Mark Stafford-Smith
Jan 20, 2006·Journal of Thrombosis and Haemostasis : JTH·X WangW A Schumacher
Jan 24, 2006·Seminars in Hematology·Heng Joo Ng, Mark A Crowther
Mar 4, 2006·British Journal of Haematology·T BaglinUNKNOWN British Committee for Standards in Haematology
Aug 3, 2007·Interactive Cardiovascular and Thoracic Surgery·Kenneth Edward McLaughlin, Joel Dunning
Oct 24, 2008·Biomacromolecules·Kamil KamińskiMaria Nowakowska
Oct 21, 2009·International Journal of Pharmaceutics·A KarewiczM Nowakowska
Apr 29, 2010·Journal of Medicinal Chemistry·Kamil KamińskiMaria Nowakowska
Aug 27, 2011·Journal of Medicinal Chemistry·Kamil KamińskiRadosław Lach

❮ Previous
Next ❯

Citations

Mar 26, 2016·Frontiers in Pharmacology·Emilia SokolowskaAndrzej Mogielnicki
Feb 15, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Kamil KamińskiKrzysztof Szczubiałka
Jul 28, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Bartlomiej KalaskaAndrzej Mogielnicki
May 26, 2016·Expert Opinion on Drug Metabolism & Toxicology·Emilia SokolowskaAndrzej Mogielnicki
Sep 11, 2013·Chemical Society Reviews·Stephen M BromfieldDavid K Smith
Aug 14, 2012·Chemical Society Reviews·Sangram Keshari SamalPeter Dubruel
Apr 19, 2013·Chemical Communications : Chem Comm·Stephen M BromfieldDavid K Smith
Jul 18, 2014·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Agnieszka ZakrzeskaEwa Chabielska
Nov 7, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Masoud FarshbafRoya Salehi
Sep 25, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Huan OuyangXiaolei Wang
Feb 15, 2013·Journal of the American Chemical Society·Stephen M BromfieldDavid K Smith
Sep 29, 2017·Journal of Medicinal Chemistry·Magdalena PachotaMaria Nowakowska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Photodermatology, Photoimmunology & Photomedicine
E IvancicF Trautinger
Clinical Cardiology
C Richard Conti
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Jay B Wish
© 2021 Meta ULC. All rights reserved